PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway

Patients with colorectal cancer (CRC) with liver metastasis or drug resistance have a poor prognosis. Previous research has demonstrated that PPP2R1B inactivation results in the development of CRC. However, th...

Source: Cancer Cell International - March 1, 2024 Category: Cancer & Oncology Authors: Wei Liu, Jingtong Tang, Wei Gao, Jian Sun, Gang Liu and Jianping Zhou Tags: Research Source Type: research